237 related articles for article (PubMed ID: 23081990)
1. The angiogenic factor secretoneurin induces coronary angiogenesis in a model of myocardial infarction by stimulation of vascular endothelial growth factor signaling in endothelial cells.
Albrecht-Schgoer K; Schgoer W; Holfeld J; Theurl M; Wiedemann D; Steger C; Gupta R; Semsroth S; Fischer-Colbrie R; Beer AG; Stanzl U; Huber E; Misener S; Dejaco D; Kishore R; Pachinger O; Grimm M; Bonaros N; Kirchmair R
Circulation; 2012 Nov; 126(21):2491-501. PubMed ID: 23081990
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia up-regulates the angiogenic cytokine secretoneurin via an HIF-1alpha- and basic FGF-dependent pathway in muscle cells.
Egger M; Schgoer W; Beer AG; Jeschke J; Leierer J; Theurl M; Frauscher S; Tepper OM; Niederwanger A; Ritsch A; Kearney M; Wanschitz J; Gurtner GC; Fischer-Colbrie R; Weiss G; Piza-Katzer H; Losordo DW; Patsch JR; Schratzberger P; Kirchmair R
FASEB J; 2007 Sep; 21(11):2906-17. PubMed ID: 17504977
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism.
Schgoer W; Theurl M; Jeschke J; Beer AG; Albrecht K; Gander R; Rong S; Vasiljevic D; Egger M; Wolf AM; Frauscher S; Koller B; Tancevski I; Patsch JR; Schratzberger P; Piza-Katzer H; Ritsch A; Bahlmann FH; Fischer-Colbrie R; Wolf D; Kirchmair R
Circ Res; 2009 Nov; 105(10):994-1002. PubMed ID: 19797703
[TBL] [Abstract][Full Text] [Related]
4. The neuropeptide secretoneurin acts as a direct angiogenic cytokine in vitro and in vivo.
Kirchmair R; Gander R; Egger M; Hanley A; Silver M; Ritsch A; Murayama T; Kaneider N; Sturm W; Kearny M; Fischer-Colbrie R; Kircher B; Gaenzer H; Wiedermann CJ; Ropper AH; Losordo DW; Patsch JR; Schratzberger P
Circulation; 2004 Feb; 109(6):777-83. PubMed ID: 14970115
[TBL] [Abstract][Full Text] [Related]
5. Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influencing systemic atherosclerosis.
Theurl M; Schgoer W; Albrecht-Schgoer K; Lener D; Wolf D; Wolf M; Demetz E; Tymoszuk P; Tancevski I; Fischer-Colbrie R; Franz WM; Marschang P; Kirchmair R
Cardiovasc Res; 2015 Jan; 105(1):96-106. PubMed ID: 25377726
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticular delivery system for a secretoneurin derivative induces angiogenesis in a hind limb ischemia model.
Albrecht-Schgoer K; Barthelmes J; Schgoer W; Theurl M; Nardin I; Lener D; Gutmann C; Dünnhaupt S; Bernkop-Schnürch A; Kirchmair R
J Control Release; 2017 Mar; 250():1-8. PubMed ID: 28167285
[TBL] [Abstract][Full Text] [Related]
7. Topical secretoneurin gene therapy accelerates diabetic wound healing by interaction between heparan-sulfate proteoglycans and basic FGF.
Albrecht-Schgoer K; Schgoer W; Theurl M; Stanzl U; Lener D; Dejaco D; Zelger B; Franz WM; Kirchmair R
Angiogenesis; 2014 Jan; 17(1):27-36. PubMed ID: 23918206
[TBL] [Abstract][Full Text] [Related]
8. Secretoneurin, an angiogenic neuropeptide, induces postnatal vasculogenesis.
Kirchmair R; Egger M; Walter DH; Eisterer W; Niederwanger A; Woell E; Nagl M; Pedrini M; Murayama T; Frauscher S; Hanley A; Silver M; Brodmann M; Sturm W; Fischer-Colbrie R; Losordo DW; Patsch JR; Schratzberger P
Circulation; 2004 Aug; 110(9):1121-7. PubMed ID: 15326074
[TBL] [Abstract][Full Text] [Related]
9. Hypoxic preconditioning triggers myocardial angiogenesis: a novel approach to enhance contractile functional reserve in rat with myocardial infarction.
Sasaki H; Fukuda S; Otani H; Zhu L; Yamaura G; Engelman RM; Das DK; Maulik N
J Mol Cell Cardiol; 2002 Mar; 34(3):335-48. PubMed ID: 11945025
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic and pleiotropic effects of VEGF165 and HGF combined gene therapy in a rat model of myocardial infarction.
Makarevich PI; Dergilev KV; Tsokolaeva ZI; Boldyreva MA; Shevchenko EK; Gluhanyuk EV; Gallinger JO; Menshikov MY; Parfyonova YV
PLoS One; 2018; 13(5):e0197566. PubMed ID: 29787588
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
12. Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway.
Yao YY; Yin H; Shen B; Smith RS; Liu Y; Gao L; Chao L; Chao J
Cardiovasc Res; 2008 Dec; 80(3):354-64. PubMed ID: 18689794
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Cardiomyocyte α1A-Adrenergic Receptors Attenuates Postinfarct Remodeling by Inducing Angiogenesis Through Heterocellular Signaling.
Zhao X; Balaji P; Pachon R; Beniamen DM; Vatner DE; Graham RM; Vatner SF
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2451-9. PubMed ID: 26338300
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of protein kinase Calpha prevents endothelial cell migration and vascular tube formation in vitro and myocardial neovascularization in vivo.
Wang A; Nomura M; Patan S; Ware JA
Circ Res; 2002 Mar; 90(5):609-16. PubMed ID: 11909826
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of coronary angiogenesis in response to stretch: role of VEGF and TGF-beta.
Zheng W; Seftor EA; Meininger CJ; Hendrix MJ; Tomanek RJ
Am J Physiol Heart Circ Physiol; 2001 Feb; 280(2):H909-17. PubMed ID: 11158993
[TBL] [Abstract][Full Text] [Related]
16. Astragalosides promote angiogenesis via vascular endothelial growth factor and basic fibroblast growth factor in a rat model of myocardial infarction.
Yu JM; Zhang XB; Jiang W; Wang HD; Zhang YN
Mol Med Rep; 2015 Nov; 12(5):6718-26. PubMed ID: 26352430
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor.
Kaga S; Zhan L; Matsumoto M; Maulik N
J Mol Cell Cardiol; 2005 Nov; 39(5):813-22. PubMed ID: 16198371
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside-Rg1 enhances angiogenesis and ameliorates ventricular remodeling in a rat model of myocardial infarction.
Yin H; Liu Z; Li F; Ni M; Wang B; Qiao Y; Xu X; Zhang M; Zhang J; Lu H; Zhang Y
J Mol Med (Berl); 2011 Apr; 89(4):363-75. PubMed ID: 21327539
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat--angiogenesis and angioma formation.
Schwarz ER; Speakman MT; Patterson M; Hale SS; Isner JM; Kedes LH; Kloner RA
J Am Coll Cardiol; 2000 Apr; 35(5):1323-30. PubMed ID: 10758976
[TBL] [Abstract][Full Text] [Related]
20. Testosterone replacement therapy promotes angiogenesis after acute myocardial infarction by enhancing expression of cytokines HIF-1a, SDF-1a and VEGF.
Chen Y; Fu L; Han Y; Teng Y; Sun J; Xie R; Cao J
Eur J Pharmacol; 2012 Jun; 684(1-3):116-24. PubMed ID: 22484505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
